← Evidence map

ArticleLancet regional health. Americas2026

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada.

Sara Carazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 41853777